Brain White Matter Microstructure as a Risk Factor for Cognitive Decline After Chemotherapy for Breast Cancer. de Ruiter MB, Reneman L, Kieffer JM, Oldenburg HSA, et al. J Clin Oncol 2021 Sep 30:JCO2100627. doi: 10.1200/JCO.21.00627.

Read + Share

Amedeo Smart

Independent Medical Education

de Ruiter MB, Reneman L, Kieffer JM, Oldenburg HSA, et al. Brain White Matter Microstructure as a Risk Factor for Cognitive Decline After Chemotherapy for Breast Cancer. J Clin Oncol 2021 Sep 30:JCO2100627. doi: 10.1200/JCO.21.00627.
PMID: 34591652